Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma. Dasgupta P, Lin H, Kumar G, Soomro Z, et al. J Neurooncol 2025 Jun 25. doi: 10.1007/s11060-025-05131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dasgupta P, Lin H, Kumar G, Soomro Z, et al. Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma. J Neurooncol 2025 Jun 25. doi: 10.1007/s11060-025-05131.
PMID: 40560330